Are the type of gastrectomy and the presence of complications prognostic factors in patients with gastric cancer without lymph node involvement?

Orhan Uzun 1 * , Selçuk Gülmez 1, Aziz Serkan Senger 1, Cem Batuhan Ofluoğlu 1, Tolga Olmez 1, Hilmi Bozkurt 1, Erdal Polat 1, Mustafa Duman 1
More Detail
1 Gastroenterolgical Surgery Department, University of Health Sciences, Kartal Kosuyolu Higher Specialty Training and Research Hospital, Istanbul, Turkey
* Corresponding Author
J CLIN MED KAZ, Volume 4, Issue 58, pp. 23-27. https://doi.org/10.23950/1812-2892-JCMK-00783
OPEN ACCESS 1921 Views 1433 Downloads
Download Full Text (PDF)

ABSTRACT

Objective: Lymph node involvement is one of the leading prognostic factors in patients with gastric cancer without distant metastasis, although disease-related death also occurs in patients without lymph node involvement. The present study investigates whether gastrectomy type and complication presence is a prognostic factor in gastric cancer patients without lymph node involvement.
Material and methods: The data of 262 patients who underwent curative gastrectomy at our clinic between November 2006 and December 2018 was reviewed retrospectively.
Results: No lymph node involvement was identified in 33.2% of the patients who underwent curative gastrectomy, and survival in this group was better than in the patient group with lymph node involvement (75.9% vs. 32.6%). A comparison of the two groups revealed significant differences in terms of Borrmann’s classification, Lauren classification, T stage, vascular invasion, perineural invasion, tumor diameter and total number of lymph nodes. Disease-related death occurs also in patients without lymph node involvement, with tumor diameter, T stage, gastrectomy type and the presence of complications all found to be factors affecting the risk of death.
Conclusion: Patients without lymph node involvement have a better prognosis, and aside from tumor diameter and T stage, the present study found gastrectomy type and the presence of complications to be prognostic risk factors.
Keywords: negative lymph nodes, prognostic factors, gastric cancer, overall survival

CITATION

Uzun O, Gülmez S, Senger AS, Ofluoğlu CB, Olmez T, Bozkurt H, et al. Are the type of gastrectomy and the presence of complications prognostic factors in patients with gastric cancer without lymph node involvement?. Journal of Clinical Medicine of Kazakhstan. 2020;4(58):23-7. https://doi.org/10.23950/1812-2892-JCMK-00783

REFERENCES

  • Stewart C, Chao J, Chen Y.J, et al. Multimodality management of locally advanced gastric cancer—the timing and extent of surgery. Transl Gastroenterol Hepatol. 2019; 4:42-42. doi:10.21037/tgh.2019.05.02
  • Marano L, Polom K, Patriti A, et al. Surgical management of advanced gastric cancer: An evolving issue. Eur J Surg Oncol. 2016; 42(1):18-27. doi:10.1016/j.ejso.2015.10.016
  • Zhou Y, Cui J, Huang F, et al. Scandinavian journal of surgery SJS Prognostic Factors For survival in node-negative gastric cancer Patients Who underWent curative resection. Scand J Surg. 2017; 106(3):235-40. doi:10.1177/1457496916677878
  • Zhao B, Huang X, Zhang J, et al. Clinicopathologic factors associated with recurrence and long-term survival in node-negative advanced gastric cancer patients. Rev Esp Enferm Dig. 2019; 111(2):111-20. doi:10.17235/reed.2018.5829/2018
  • Jin LX, Moses LE, Hart Squires M, et al. Factors associated with recurrence and survival in lymph node-negative gastric adenocarcinoma: A 7-institution study of the us gastric cancer collaborative. Annals of Surgery. Lippincott Williams and Wilkins. 2015; 999-1005. doi:10.1097/SLA.0000000000001084
  • Japanese gastric cancer treatment guidelines 2010 (ver. 3). Japanese Gastric Cancer Association. 2011. doi:10.1007/s10120-011-0040-6
  • Sun P, Xiang J, Chen Z. Meta-analysis of adjuvant chemotherapy after radical surgery for advanced gastric cancer. 2009; 26-33. doi:10.1002/bjs.6408
  • Siewert JR, Bottcher K, Stein HJ, et al. Relevant Prognostic Factors in Gastric Cancer Ten-Year Results of the German Gastric Cancer Study. Ann Surg. 1998; 228(4):449-61. doi: 10.1097/00000658-199810000-00002.
  • Meyer C, Lozac’h P, Rohr S, et al. French Association of Surgery. Gastric cancer: the French survey. Acta Gastroenterol Belg. 65(3):161-5.
  • Wohnrath DR, Araujo RLC. D2 lymphadenectomy for gastric cancer as an independent prognostic factor of 10-year overall survival. Eur J Surg Oncol. 2019; 45(3):446-53. doi:10.1016/j.ejso.2018.10.538
  • Aurello P, Berardi G, Tierno SM, et al. Influence of perineural invasion in predicting overall survival and disease-free survival in patients With locally advanced gastric cancer. Am J Surg. 2017; 213(4):748-53. doi:10.1016/j.amjsurg.2016.05.022
  • Wang H-M, Huang C-M, Zheng C-H, et al. Tumor size as a prognostic factor in patients with advanced gastric cancer in the lower third of the stomach. World J Gastroenterol. 2012; 18(38):5470-5. doi:10.3748/wjg.v18.i38.5470
  • Donida MGBM, Ratti LTM, Benzoni CPI, Aldighieri DLF. Prognostic factors associated with survival in a large cohort of gastric cancer patients resected over a decade at a single Italian center : the Cremona experience. Clin Transl Oncol. 2019; (0123456789). doi:10.1007/s12094-019-02220-w
  • Li X, Zhu X, Wang Y, et al. Prognostic value and association of Lauren classification with VEGF and VEGFR-2 expression in gastric cancer. Oncol Lett. 2019; 18(5):4891-9. doi:10.3892/ol.2019.10820
  • Cortesini C. Clinicopathologic Characteristics and Outcome Indicators in Node-Negative. 2000; (September 1999):30-2. doi:10.1002/1096-9098(200005)74:1<30::AID-JSO7>3.0.CO;2-2
  • Qiu MZ, Wang ZQ, Luo HY, et al. Prognostic analysis in node-negative gastric cancer patients in China. Tumor Biol. 2011; 32(3):489-2. doi:10.1007/s13277-010-0142-5
  • Liu X, Cai H, Shi Y, Wang Y. Prognostic Factors in Patients with Node-Negative Gastric Cancer: A Single Center Experience from China. J Gastrointest Surg. 2012; 16(6):1123-7. doi:10.1007/s11605-012-1881-y
  • Hsu J Te, Le PH, Kuo CJ, et al. Survival impact of the number of lymph node retrieved on patients with node-negative gastric cancer: More is better? Transl Gastroenterol Hepatol. 2017; 2. doi:10.21037/tgh.2017.12.02
  • Deng J, You Q, Gao Y, et al. Prognostic value of perineural invasion in gastric cancer: A systematic review and meta-analysis. PLoS One. 2014; 9(2). doi:10.1371/journal.pone.0088907
  • Deng J, Liang H, Sun DM, et al. Prognosis of Gastric Cancer Patients with Node-Negative Metastasis Following Curative Resection: Outcomes of the Survival and Recurrence.
  • Lee EW, Lee WY, Koo HS. Prognostic factors for node-negative advanced gastric cancer after curative gastrectomy. J Gastric Cancer. 2016; 16(3):161-6. doi:10.5230/jgc.2016.16.3.161
  • Lee CC, Wu CW, Lo SS, et al. Survival predictors in patients with node-negative gastric carcinoma. J Gastroenterol Hepatol. 2007; 22(7):1014-8. doi:10.1111/j.1440-1746.2006.04488.x